Evaluation of regulatory T lymphocytes and IL2Ra and FOXP3 gene expression in peripheral mononuclear cells from patients with amyotrophic lateral sclerosis
Background Loss of neuroprotective role of CD4 + helper T cells, regulatory T cells, and M2 microglia constitutively results in the rapid neural death in the “rapidly progressive phase” of amyotrophic lateral sclerosis (ALS). Aim We aimed to investigate relative count of CD4 + and regulatory T lymph...
Saved in:
Published in: | Irish journal of medical science Vol. 187; no. 4; pp. 1065 - 1071 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
London
Springer London
01-11-2018
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background
Loss of neuroprotective role of CD4
+
helper T cells, regulatory T cells, and M2 microglia constitutively results in the rapid neural death in the “rapidly progressive phase” of amyotrophic lateral sclerosis (ALS).
Aim
We aimed to investigate relative count of CD4
+
and regulatory T lymphocytes and expression level of IL2Ra and FOXP3 genes in peripheral blood mononuclear cells (PBMCs) from patients with ALS.
Method
We performed a flow cytometric analysis on PBMC from 38 patients with ALS and 32 controls to determine the count of CD4
+
and CD4
+
CD25
+
cells. Quantitative real-time PCR analyses were implemented to determine the level of expression of FOXP3 and IL-2Rα (CD25) genes in the peripheral blood mononucleated cells.
Results
We found a significant higher proportion of CD4
+
T cells (
p
value < 0.001), along with a significantly reduced proportion of CD4
+
CD25
+
Treg cells (
p
value
=
0.001,
p
value
=
0.02), in the peripheral blood of patient’s with ALS.
Conclusion
The results of our study are in line with the hypothesis that in the early phase of ALS, neuroprotective helper T cells infiltrate in the affected areas in the lumbar spinal cord. This was reflected in higher peripheral percentage of CD4
+
helper T cells and higher expression of FOXP3 and IL-2Rα. The observed demise in the number of active CD4
+
CD25
+
regulatory T cells might indicate early signs of progression to later stages of ALS in our study group. Interestingly, disease duration was the sole independent significant determining factor that predicted CD4+CD25+ regulatory T cell counts in the peripheral blood of patients at various stages of ALS, according to a logistic regression model. |
---|---|
AbstractList | Loss of neuroprotective role of CD4
helper T cells, regulatory T cells, and M2 microglia constitutively results in the rapid neural death in the "rapidly progressive phase" of amyotrophic lateral sclerosis (ALS).
We aimed to investigate relative count of CD4
and regulatory T lymphocytes and expression level of IL2Ra and FOXP3 genes in peripheral blood mononuclear cells (PBMCs) from patients with ALS.
We performed a flow cytometric analysis on PBMC from 38 patients with ALS and 32 controls to determine the count of CD4
and CD4
CD25
cells. Quantitative real-time PCR analyses were implemented to determine the level of expression of FOXP3 and IL-2Rα (CD25) genes in the peripheral blood mononucleated cells.
We found a significant higher proportion of CD4
T cells (p value < 0.001), along with a significantly reduced proportion of CD4
CD25
Treg cells (p value = 0.001, p value = 0.02), in the peripheral blood of patient's with ALS.
The results of our study are in line with the hypothesis that in the early phase of ALS, neuroprotective helper T cells infiltrate in the affected areas in the lumbar spinal cord. This was reflected in higher peripheral percentage of CD4
helper T cells and higher expression of FOXP3 and IL-2Rα. The observed demise in the number of active CD4
CD25
regulatory T cells might indicate early signs of progression to later stages of ALS in our study group. Interestingly, disease duration was the sole independent significant determining factor that predicted CD4+CD25+ regulatory T cell counts in the peripheral blood of patients at various stages of ALS, according to a logistic regression model. Background Loss of neuroprotective role of CD4 + helper T cells, regulatory T cells, and M2 microglia constitutively results in the rapid neural death in the “rapidly progressive phase” of amyotrophic lateral sclerosis (ALS). Aim We aimed to investigate relative count of CD4 + and regulatory T lymphocytes and expression level of IL2Ra and FOXP3 genes in peripheral blood mononuclear cells (PBMCs) from patients with ALS. Method We performed a flow cytometric analysis on PBMC from 38 patients with ALS and 32 controls to determine the count of CD4 + and CD4 + CD25 + cells. Quantitative real-time PCR analyses were implemented to determine the level of expression of FOXP3 and IL-2Rα (CD25) genes in the peripheral blood mononucleated cells. Results We found a significant higher proportion of CD4 + T cells ( p value < 0.001), along with a significantly reduced proportion of CD4 + CD25 + Treg cells ( p value = 0.001, p value = 0.02), in the peripheral blood of patient’s with ALS. Conclusion The results of our study are in line with the hypothesis that in the early phase of ALS, neuroprotective helper T cells infiltrate in the affected areas in the lumbar spinal cord. This was reflected in higher peripheral percentage of CD4 + helper T cells and higher expression of FOXP3 and IL-2Rα. The observed demise in the number of active CD4 + CD25 + regulatory T cells might indicate early signs of progression to later stages of ALS in our study group. Interestingly, disease duration was the sole independent significant determining factor that predicted CD4+CD25+ regulatory T cell counts in the peripheral blood of patients at various stages of ALS, according to a logistic regression model. BACKGROUNDLoss of neuroprotective role of CD4+ helper T cells, regulatory T cells, and M2 microglia constitutively results in the rapid neural death in the "rapidly progressive phase" of amyotrophic lateral sclerosis (ALS).AIMWe aimed to investigate relative count of CD4+ and regulatory T lymphocytes and expression level of IL2Ra and FOXP3 genes in peripheral blood mononuclear cells (PBMCs) from patients with ALS.METHODWe performed a flow cytometric analysis on PBMC from 38 patients with ALS and 32 controls to determine the count of CD4+ and CD4+CD25+ cells. Quantitative real-time PCR analyses were implemented to determine the level of expression of FOXP3 and IL-2Rα (CD25) genes in the peripheral blood mononucleated cells.RESULTSWe found a significant higher proportion of CD4+ T cells (p value < 0.001), along with a significantly reduced proportion of CD4+CD25+ Treg cells (p value = 0.001, p value = 0.02), in the peripheral blood of patient's with ALS.CONCLUSIONThe results of our study are in line with the hypothesis that in the early phase of ALS, neuroprotective helper T cells infiltrate in the affected areas in the lumbar spinal cord. This was reflected in higher peripheral percentage of CD4+ helper T cells and higher expression of FOXP3 and IL-2Rα. The observed demise in the number of active CD4+CD25+ regulatory T cells might indicate early signs of progression to later stages of ALS in our study group. Interestingly, disease duration was the sole independent significant determining factor that predicted CD4+CD25+ regulatory T cell counts in the peripheral blood of patients at various stages of ALS, according to a logistic regression model. |
Author | Sadr, Maryam Tavasolian, Parsova Maserrat, Marziyeh Habibi, Sima Zamani, Babak Rezaei, Nima Noorbakhsh, Farshid Masoumi, Farimah Rashid Chehreh Bargh, Sara Tafakhori, Abbas Namdar, Afshin Azimi, Maryam Rahmani, Farzaneh Ahmadi, Mona |
Author_xml | – sequence: 1 givenname: Sara surname: Rashid Chehreh Bargh fullname: Rashid Chehreh Bargh, Sara organization: Department of Immunology, School of Medicine, Tehran University of Medical Sciences – sequence: 2 givenname: Abbas surname: Tafakhori fullname: Tafakhori, Abbas organization: Iranian Center of Neurological Research, Tehran University of Medical Sciences, NeuroImmunology Research Association (NIRA), Universal Scientific Education and Research Network (USERN) – sequence: 3 givenname: Farimah surname: Masoumi fullname: Masoumi, Farimah organization: Department of Immunology, School of Medicine, Tehran University of Medical Sciences – sequence: 4 givenname: Farzaneh surname: Rahmani fullname: Rahmani, Farzaneh organization: NeuroImaging Network (NIN), Universal Scientific Education and Research Network (USERN) – sequence: 5 givenname: Mona surname: Ahmadi fullname: Ahmadi, Mona organization: Iranian Center of Neurological Research, Tehran University of Medical Sciences – sequence: 6 givenname: Afshin surname: Namdar fullname: Namdar, Afshin organization: Department of Immunology, School of Medicine, Tehran University of Medical Sciences – sequence: 7 givenname: Maryam surname: Azimi fullname: Azimi, Maryam organization: Department of Immunology, School of Medicine, Tehran University of Medical Sciences – sequence: 8 givenname: Parsova surname: Tavasolian fullname: Tavasolian, Parsova organization: Department of Immunology, School of Medicine, Tehran University of Medical Sciences – sequence: 9 givenname: Sima surname: Habibi fullname: Habibi, Sima organization: Department of Immunology, School of Medicine, Tehran University of Medical Sciences – sequence: 10 givenname: Babak surname: Zamani fullname: Zamani, Babak organization: Rasul’e Akram hospital, Iran University of Medical Sciences – sequence: 11 givenname: Marziyeh surname: Maserrat fullname: Maserrat, Marziyeh organization: Iranian Center of Neurological Research, Tehran University of Medical Sciences – sequence: 12 givenname: Maryam surname: Sadr fullname: Sadr, Maryam organization: Molecular Immunology Research Center, Tehran University of Medical Sciences – sequence: 13 givenname: Farshid surname: Noorbakhsh fullname: Noorbakhsh, Farshid organization: Department of Immunology, School of Medicine, Tehran University of Medical Sciences – sequence: 14 givenname: Nima surname: Rezaei fullname: Rezaei, Nima email: rezaei_nima@tums.ac.ir organization: Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Molecular Immunology Research Center, Tehran University of Medical Sciences, Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29574662$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uctu1EAQHKEgsgl8ABc0Ry4O8_LriKIsibRSIhQkbqPecXvXkT1jpm3A35KfzWw2cMxpRuqq6uqqM3big0fGPkpxIYUov5CUlckzIatMlrXO1Bu2klWhM6MLdcJWQiiZSVXkp-yM6EEIXevCvGOnqs5LUxRqxR6vfkM_w9QFz0PLI-7mHqYQF37P-2UY98EtExIH3_CbjfoOz7_17c87zXfokePfMSLRgd95PmLsxj1G6PkQktvZ9QiRO-x74m0MAx_TLvQT8T_dtOcwLGGKYdx3jqe9z0RKnBioo_fsbQs94YeX95z9WF_dX15nm9tvN5dfN5nTxkxZURpXglFY1jW0sqq0Am2aRm6dauqyBuGUdDlIqIQo0lRtWymNEimCrWlRn7PPR90xhl8z0mSHjg6WwWOYyaoUcAqrVHmCyiPUJYcUsbVj7AaIi5XCHjqxx05sothDJ1YlzqcX-Xk7YPOf8a-EBFBHAKWR32G0D2GOPp38iuoTRIebbw |
CitedBy_id | crossref_primary_10_1007_s00415_022_11185_w crossref_primary_10_1093_cei_uxac084 crossref_primary_10_1111_ene_14287 crossref_primary_10_3389_fimmu_2022_1047550 crossref_primary_10_1080_21678421_2021_1961807 crossref_primary_10_1080_21678421_2024_2351187 crossref_primary_10_1016_j_jocn_2022_01_016 crossref_primary_10_1684_ecn_2019_0424 crossref_primary_10_3389_fnagi_2020_572090 crossref_primary_10_3390_cells13090749 |
Cites_doi | 10.1093/brain/awr351 10.1038/nature11314 10.1080/146608200300079536 10.1007/s11481-013-9489-x 10.1212/WNL.47.4_Suppl_2.71S 10.1016/j.bbi.2010.12.008 10.1093/ije/dyw061 10.1093/brain/awr365 10.1016/j.mcp.2010.10.003 10.1016/S0022-510X(99)00210-5 10.1093/brain/awr074 10.1007/s11481-015-9639-4 10.1073/pnas.0807419105 10.1038/nature20413 10.1371/journal.pone.0002740 10.1038/nprot.2008.73 10.1126/science.1134108 10.1186/s12974-015-0254-3 10.1016/s1474-4422(16)30199-5 10.1073/pnas.0607423103 10.1002/emmm.201201544 10.1016/j.jneuroim.2015.06.013 |
ContentType | Journal Article |
Copyright | Royal Academy of Medicine in Ireland 2018 |
Copyright_xml | – notice: Royal Academy of Medicine in Ireland 2018 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1007/s11845-018-1793-2 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1863-4362 |
EndPage | 1071 |
ExternalDocumentID | 10_1007_s11845_018_1793_2 29574662 |
Genre | Journal Article |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0VY 199 1N0 203 28- 29J 29~ 2J2 2JN 2JY 2KG 2LR 2VQ 2~H 30V 4.4 406 408 40D 40E 53G 5GY 5VS 67Z 6NX 78A 875 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKSU AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABDZT ABECU ABFGW ABFTV ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABWNU ABXPI ACBMV ACBRV ACBYP ACGFO ACGFS ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACSNA ACTTH ACUDM ACVWB ACWMK ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADQRH ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEEQQ AEFTE AEGAL AEGNC AEGXH AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFEXP AFFNX AFLOW AFNRJ AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHSBF AHYZX AIAGR AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BGNMA CAG COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GRRUI HF~ HG5 HG6 HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZQ I~X I~Z J-C J0Z JBSCW JZLTJ KDC KOV KPH LLZTM M4Y MA- MK0 N2Q NDZJH NF0 NPVJJ NQJWS NU0 O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PT4 PT5 QOK QOR R4E R89 R9I RHV RNI ROL RPX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 XAX XFK YLTOR Z45 Z7U Z7W Z82 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ZXP ~A9 ~EX 0R~ AACDK AAEOY AAJBT AASML AAYZH ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AGQEE AGRTI AIGIU AJOOF CGR CUY CVF ECM EIF H13 NPM SJYHP AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c344t-674c7a42e799af18832a34dd1bc2d979a0c21c5a1a80068322bf11420746b4fe3 |
IEDL.DBID | AEJHL |
ISSN | 0021-1265 |
IngestDate | Sat Oct 26 00:49:54 EDT 2024 Fri Nov 22 01:10:28 EST 2024 Wed Oct 16 00:50:30 EDT 2024 Sat Dec 16 12:04:56 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Amyotrophic lateral sclerosis IL-2Rα CD25 FOXP3 T helper Regulatory T cell |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c344t-674c7a42e799af18832a34dd1bc2d979a0c21c5a1a80068322bf11420746b4fe3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 29574662 |
PQID | 2018662725 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2018662725 crossref_primary_10_1007_s11845_018_1793_2 pubmed_primary_29574662 springer_journals_10_1007_s11845_018_1793_2 |
PublicationCentury | 2000 |
PublicationDate | 2018-11-01 |
PublicationDateYYYYMMDD | 2018-11-01 |
PublicationDate_xml | – month: 11 year: 2018 text: 2018-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: Ireland |
PublicationTitle | Irish journal of medical science |
PublicationTitleAbbrev | Ir J Med Sci |
PublicationTitleAlternate | Ir J Med Sci |
PublicationYear | 2018 |
Publisher | Springer London |
Publisher_xml | – name: Springer London |
References | Cooper-KnockJHewittCHighleyJRBrockingtonAMilanoAManSMartindaleJHartleyJWalshTGelsthorpeCBaxterLForsterGFoxMBuryJMokKMcDermottCJTraynorBJKirbyJWhartonSBIncePGHardyJShawPJClinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72Brain J Neurol2012135Pt 375176410.1093/brain/awr365 NeumannMSampathuDMKwongLKTruaxACMicsenyiMCChouTTBruceJSchuckTGrossmanMClarkCMMcCluskeyLFMillerBLMasliahEMackenzieIRFeldmanHFeidenWKretzschmarHATrojanowskiJQLeeVMUbiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisScience (New York, NY)200631457961301331:CAS:528:DC%2BD28XhtVCiurrL10.1126/science.1134108 CedarbaumJMStamblerNMaltaEFullerCHiltDThurmondBNakanishiAThe ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)J Neurol Sci19991691–213211:STN:280:DC%2BD3c%2FgvFKqtg%3D%3D10.1016/S0022-510X(99)00210-5 Marin B, Boumediene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, Copetti M, Preux PM, Beghi E (2016) Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol:dyw061. https://doi.org/10.1093/ije/dyw061 RocheJCRojas-GarciaRScottKMScottonWEllisCEBurmanRWijesekeraLTurnerMRLeighPNShawCEAl-ChalabiAA proposed staging system for amyotrophic lateral sclerosisBrain J Neurol2012135Pt 384785210.1093/brain/awr351 BeersDRHenkelJSZhaoWWangJAppelSHCD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALSProc Natl Acad Sci U S A200810540155581556310.1073/pnas.080741910525474192547419 HenkelJSBeersDRWenSRiveraALToennisKMAppelJEZhaoWMooreDHPowellSZAppelSHRegulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survivalEMBO Mol Med20135164791:CAS:528:DC%2BC3sXntFWl10.1002/emmm.20120154423143995 Di PietroFOrtenziFTilioMConcettiFNapolioniVGenomic DNA extraction from whole blood stored from 15- to 30-years at −20 degrees C by rapid phenol-chloroform protocol: a useful tool for genetic epidemiology studiesMol Cell Probes201125144481:CAS:528:DC%2BC3MXhs1antrw%3D10.1016/j.mcp.2010.10.00321029772 LeeYMorrisonBMLiYLengacherSFarahMHHoffmanPNLiuYTsingaliaAJinLZhangPWPellerinLMagistrettiPJRothsteinJDOligodendroglia metabolically support axons and contribute to neurodegenerationNature201248774084434481:CAS:528:DC%2BC38XhtFWjsb3F10.1038/nature1131434087923408792 ZhaoWBeersDRAppelSHImmune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosisJ Neuroimmune Pharmacol20138488889910.1007/s11481-013-9489-x41264254126425 ChanAYanJCsurhesPGreerJMcCombePCirculating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: effect on outcomeJ Neuroimmunol201528642471:CAS:528:DC%2BC2MXhtlymtL7M10.1016/j.jneuroim.2015.06.013 BrooksBRNatural history of ALS symptoms, strength, pulmonary function, and disabilityNeurology1996474 Suppl 271S82S10.1212/WNL.47.4_Suppl_2.71S SchmittgenTDLivakKJAnalyzing real-time PCR data by the comparative C(T) methodNat Protoc200836110111081:CAS:528:DC%2BD1cXmvVemt7c%3D10.1038/nprot.2008.7318546601 BrooksBRMillerRGSwashMMunsatTLEl Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosisAmyotroph Lateral Scler Other Motor Neuron Disord2000152932991:STN:280:DC%2BD3Mvhs1Ghsg%3D%3D10.1080/14660820030007953611464847 SheeanRKWestonRHPereraNDD’AmicoANuttSLTurnerBJEffect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 miceJ Neuroinflammation201512401:CAS:528:DC%2BC2MXkvFKgtb0%3D10.1186/s12974-015-0254-343593944359394 TaylorJPBrownRHJrClevelandDWDecoding ALS: from genes to mechanismNature2016539762819720610.1038/nature2041355850175585017 BeersDRZhaoWLiaoBKanoOWangJHuangAAppelSHHenkelJSNeuroinflammation modulates distinct regional and temporal clinical responses in ALS miceBrain Behav Immun2011255102510351:CAS:528:DC%2BC3MXntlGlu7w%3D10.1016/j.bbi.2010.12.008 GendelmanHEMosleyRLA perspective on roles played by innate and adaptive immunity in the pathobiology of neurodegenerative disordersJ Neuroimmune Pharmacol201510464565010.1007/s11481-015-9639-446626204662620 BanerjeeRMosleyRLReynoldsADDharAJackson-LewisVGordonPHPrzedborskiSGendelmanHEAdaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis micePLoS One2008371:CAS:528:DC%2BD1cXps1Wktr8%3D10.1371/journal.pone.000274024812772481277 Al-ChalabiAHardimanOKiernanMCChioARix-BrooksBvan den BergLHAmyotrophic lateral sclerosis: moving towards a new classification systemLancet Neurol201615111182119410.1016/s1474-4422(16)30199-5 BeersDRHenkelJSXiaoQZhaoWWangJYenAASiklosLMcKercherSRAppelSHWild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosisProc Natl Acad Sci U S A20061034316021160261:CAS:528:DC%2BD28XhtFyku7nE10.1073/pnas.060742310316132281613228 BeersDRHenkelJSZhaoWWangJHuangAWenSLiaoBAppelSHEndogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosisBrain J Neurol2011134Pt 51293131410.1093/brain/awr074 27185810 - Int J Epidemiol. 2017 Feb 1;46(1):57-74 11464847 - Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9 26298323 - J Neuroimmunol. 2015 Sep 15;286:42-7 21596768 - Brain. 2011 May;134(Pt 5):1293-314 27830784 - Nature. 2016 Nov 10;539(7628):197-206 8858055 - Neurology. 1996 Oct;47(4 Suppl 2):S71-81; discussion S81-2 18809917 - Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15558-63 10540002 - J Neurol Sci. 1999 Oct 31;169(1-2):13-21 17023659 - Science. 2006 Oct 6;314(5796):130-3 26520433 - J Neuroimmune Pharmacol. 2015 Dec;10(4):645-50 25889790 - J Neuroinflammation. 2015 Feb 27;12:40 17043238 - Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):16021-6 21029772 - Mol Cell Probes. 2011 Feb;25(1):44-8 22366792 - Brain. 2012 Mar;135(Pt 3):751-64 22271664 - Brain. 2012 Mar;135(Pt 3):847-52 23143995 - EMBO Mol Med. 2013 Jan;5(1):64-79 22801498 - Nature. 2012 Jul 26;487(7408):443-8 18546601 - Nat Protoc. 2008;3(6):1101-8 23881705 - J Neuroimmune Pharmacol. 2013 Sep;8(4):888-99 21176785 - Brain Behav Immun. 2011 Jul;25(5):1025-35 18648532 - PLoS One. 2008 Jul 23;3(7):e2740 27647646 - Lancet Neurol. 2016 Oct;15(11):1182-94 JM Cedarbaum (1793_CR15) 1999; 169 RK Sheean (1793_CR18) 2015; 12 A Chan (1793_CR19) 2015; 286 R Banerjee (1793_CR20) 2008; 3 DR Beers (1793_CR21) 2008; 105 HE Gendelman (1793_CR10) 2015; 10 DR Beers (1793_CR22) 2011; 134 DR Beers (1793_CR8) 2006; 103 W Zhao (1793_CR17) 2013; 8 1793_CR1 DR Beers (1793_CR16) 2011; 25 M Neumann (1793_CR7) 2006; 314 BR Brooks (1793_CR3) 1996; 47 JC Roche (1793_CR4) 2012; 135 Y Lee (1793_CR9) 2012; 487 F Pietro Di (1793_CR13) 2011; 25 BR Brooks (1793_CR11) 2000; 1 TD Schmittgen (1793_CR14) 2008; 3 J Cooper-Knock (1793_CR5) 2012; 135 JS Henkel (1793_CR12) 2013; 5 JP Taylor (1793_CR6) 2016; 539 A Al-Chalabi (1793_CR2) 2016; 15 |
References_xml | – volume: 135 start-page: 847 issue: Pt 3 year: 2012 ident: 1793_CR4 publication-title: Brain J Neurol doi: 10.1093/brain/awr351 contributor: fullname: JC Roche – volume: 487 start-page: 443 issue: 7408 year: 2012 ident: 1793_CR9 publication-title: Nature doi: 10.1038/nature11314 contributor: fullname: Y Lee – volume: 1 start-page: 293 issue: 5 year: 2000 ident: 1793_CR11 publication-title: Amyotroph Lateral Scler Other Motor Neuron Disord doi: 10.1080/146608200300079536 contributor: fullname: BR Brooks – volume: 8 start-page: 888 issue: 4 year: 2013 ident: 1793_CR17 publication-title: J Neuroimmune Pharmacol doi: 10.1007/s11481-013-9489-x contributor: fullname: W Zhao – volume: 47 start-page: 71S issue: 4 Suppl 2 year: 1996 ident: 1793_CR3 publication-title: Neurology doi: 10.1212/WNL.47.4_Suppl_2.71S contributor: fullname: BR Brooks – volume: 25 start-page: 1025 issue: 5 year: 2011 ident: 1793_CR16 publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2010.12.008 contributor: fullname: DR Beers – ident: 1793_CR1 doi: 10.1093/ije/dyw061 – volume: 135 start-page: 751 issue: Pt 3 year: 2012 ident: 1793_CR5 publication-title: Brain J Neurol doi: 10.1093/brain/awr365 contributor: fullname: J Cooper-Knock – volume: 25 start-page: 44 issue: 1 year: 2011 ident: 1793_CR13 publication-title: Mol Cell Probes doi: 10.1016/j.mcp.2010.10.003 contributor: fullname: F Pietro Di – volume: 169 start-page: 13 issue: 1–2 year: 1999 ident: 1793_CR15 publication-title: J Neurol Sci doi: 10.1016/S0022-510X(99)00210-5 contributor: fullname: JM Cedarbaum – volume: 134 start-page: 1293 issue: Pt 5 year: 2011 ident: 1793_CR22 publication-title: Brain J Neurol doi: 10.1093/brain/awr074 contributor: fullname: DR Beers – volume: 10 start-page: 645 issue: 4 year: 2015 ident: 1793_CR10 publication-title: J Neuroimmune Pharmacol doi: 10.1007/s11481-015-9639-4 contributor: fullname: HE Gendelman – volume: 105 start-page: 15558 issue: 40 year: 2008 ident: 1793_CR21 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0807419105 contributor: fullname: DR Beers – volume: 539 start-page: 197 issue: 7628 year: 2016 ident: 1793_CR6 publication-title: Nature doi: 10.1038/nature20413 contributor: fullname: JP Taylor – volume: 3 issue: 7 year: 2008 ident: 1793_CR20 publication-title: PLoS One doi: 10.1371/journal.pone.0002740 contributor: fullname: R Banerjee – volume: 3 start-page: 1101 issue: 6 year: 2008 ident: 1793_CR14 publication-title: Nat Protoc doi: 10.1038/nprot.2008.73 contributor: fullname: TD Schmittgen – volume: 314 start-page: 130 issue: 5796 year: 2006 ident: 1793_CR7 publication-title: Science (New York, NY) doi: 10.1126/science.1134108 contributor: fullname: M Neumann – volume: 12 start-page: 40 year: 2015 ident: 1793_CR18 publication-title: J Neuroinflammation doi: 10.1186/s12974-015-0254-3 contributor: fullname: RK Sheean – volume: 15 start-page: 1182 issue: 11 year: 2016 ident: 1793_CR2 publication-title: Lancet Neurol doi: 10.1016/s1474-4422(16)30199-5 contributor: fullname: A Al-Chalabi – volume: 103 start-page: 16021 issue: 43 year: 2006 ident: 1793_CR8 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0607423103 contributor: fullname: DR Beers – volume: 5 start-page: 64 issue: 1 year: 2013 ident: 1793_CR12 publication-title: EMBO Mol Med doi: 10.1002/emmm.201201544 contributor: fullname: JS Henkel – volume: 286 start-page: 42 year: 2015 ident: 1793_CR19 publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2015.06.013 contributor: fullname: A Chan |
SSID | ssj0039364 |
Score | 2.2311609 |
Snippet | Background
Loss of neuroprotective role of CD4
+
helper T cells, regulatory T cells, and M2 microglia constitutively results in the rapid neural death in the... Loss of neuroprotective role of CD4 helper T cells, regulatory T cells, and M2 microglia constitutively results in the rapid neural death in the "rapidly... BACKGROUNDLoss of neuroprotective role of CD4+ helper T cells, regulatory T cells, and M2 microglia constitutively results in the rapid neural death in the... |
SourceID | proquest crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1065 |
SubjectTerms | Adult Aged Amyotrophic Lateral Sclerosis - blood Amyotrophic Lateral Sclerosis - genetics Amyotrophic Lateral Sclerosis - immunology Disease Progression Family Medicine Female Forkhead Transcription Factors - biosynthesis Forkhead Transcription Factors - blood Forkhead Transcription Factors - genetics Forkhead Transcription Factors - immunology Gene Expression General Practice Humans Interleukin-2 Receptor alpha Subunit - biosynthesis Interleukin-2 Receptor alpha Subunit - blood Interleukin-2 Receptor alpha Subunit - genetics Interleukin-2 Receptor alpha Subunit - immunology Internal Medicine Leukocytes, Mononuclear - immunology Leukocytes, Mononuclear - metabolism Male Medicine Medicine & Public Health Middle Aged Original Article T-Lymphocytes, Regulatory - immunology T-Lymphocytes, Regulatory - metabolism |
Title | Evaluation of regulatory T lymphocytes and IL2Ra and FOXP3 gene expression in peripheral mononuclear cells from patients with amyotrophic lateral sclerosis |
URI | https://link.springer.com/article/10.1007/s11845-018-1793-2 https://www.ncbi.nlm.nih.gov/pubmed/29574662 https://search.proquest.com/docview/2018662725 |
Volume | 187 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZoK6Fe2gIFtrRokDiBUtWvOD6uYFcLKg9BkXqLJo6jrliSKtmVur-FP8s4m-wKtT3ALVLiR2Y-j8cez2fGXnu02hQyi7Qm902RGY6sTjDKybWOs4QXvGXXn3w3ny-T96NAkyPWWxflz9M-Itka6k2uG61FwjmzJDBqyojM7g5NPZqwvTMcfZyc9_ZXWhl33Ms84iLWfSzzrkr-no1uuZi3wqPtrDPe_5_-HrC9zseE4QoUj9gDXz5mDz91UfQn7PdoTfENVQH16jr6ql7CBcyWpN7KLckDBSxz-HAuvmH7NP5y-VUC4c2Dv-mOz5YwLSFwJbfkBDMgTFdlYEjGGkJIoIGQvgIdeWsDYdcX8NeymtfV9dXUAbXbFmyoDElo2hyyH-PRxbtJ1F3SEDmp1DyKjXIGlfDGWix4QhYCpcpznjmRW2PxzAnuNHJMQjoK2Y-sCPm74Z6TTBVePmXb1DX_nIFAm1gR50qhUZlHNMZxLx2aTHqt9YC96ZWVXq-4ONIN63IQd0riToO4UzFgr3p1pjRiwj9j6atFk5LLkwTae0EVPlvpeV2dIOQqejlgb3utpt2gbu5v6-ifvn7BdkULi7CPc8y25_XCn7CtJl-87KD8Bzle7pc |
link.rule.ids | 315,782,786,27933,27934,41073,42142,48344,48347,48357,49649,49652,49662,52153 |
linkProvider | Springer Nature |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELagKwEX3o_yHCROoEjrVxwfV2yrruguCIrUPVkTxxGVlmSVtBL9LfxZxmmyK7RwgFukxI_MjMdjz8w3jL0JaLUpZZ5oTeabIjWcWJ1hUpBpneYZL3mHrj_7Yk6W2eEkwuTIIRemi3YfXJKdpr5MdqPDSAw0yyKkpkxI7-5FsHMxYnsHy9PTw0EBSyvTHnyZJ1ykenBm_qmT37ejKzbmFf9ot-1M7_zXhO-y272VCQc7sbjHroXqPrtx3PvRH7CfkwuQb6hLaHYF6etmCws42xKDa78lGxSwKuBoLj5j9zT9uPwkgSQuQPjRB9BWsKogoiV38ARnQFJdVxEjGRuIToEWYgIL9PCtLcR7X8Dv23rd1OffVh5o3K5hS22IRKv2Ifs6nSzez5K-TEPipVLrJDXKG1QiGGux5BnpCJSqKHjuRWGNxX0vuNfIMYsJKaRB8jJm8MZKJ7kqg3zERjS18ISBQJtZkRZKoVF5QDTG8yA9mlwGrfWYvR245c53aBzuEnc5ktsRuV0ktxNj9nrgp6M1E_8Zq1BvWkdGTxaB7wV1-HjH6IvuBMmuopdj9m7gquuXdfv3sZ7-09ev2M3Z4nju5kcnH56xW6ITkXir85yN1s0mvGDX22LzspfrX-PO8sk |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZgK1VceD-W5yBxAkWtX3F8QhXd0BWlVLBIvUWO44iVSrJKdiX2t_BnmcmjFSocELdIicfOzHg89ni-YexVcFabUuaR1ui-KTTDkdWJiwp0reM84SXv0PWPvpiTs-RwRjA5b8dcmO62-xiS7HMaCKWpWu-tinLvMvENNyZ06SwheE0ZoQ3eoVMxNWE7B_PF-3Q0xtLKeABi5hEXsR4Dm38i8vvSdMXfvBIr7Zag9NZ_D_42uzl4n3DQq8sddi1Ud9nuxyG-fo_9nF2Af0NdQtMXqq-bLSzgfIuCr_0WfVNwVQHzY_HZdU_pp7NTCaiJAcKP4WJtBcsKCEW5gy04B9T2uiLsZNcABQtaoMQWGGBdW6DzYHDft_W6qVfflh6w365hi22QXcv2PvuazhbvjqKhfEPkURLrKDbKG6dEMNa6kidoO5xURcFzLwprrNv3gnvtuEsoUQUtS15SZi9VQMlVGeQDNsGhhUcMhLOJFXGhlDMqD84Z43mQ3plcBq31lL0eJZetepSO7BKPmdidIbszYncmpuzlKNsM5xL9s6tCvWkzdIYSAsQXSPBhL_QLcgJ1WuHLKXszSjgbpnv7974e_9PXL9ju6WGaHc9PPjxhN0SnIXTY85RN1s0mPGPX22LzfFDxX4Ot-2A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+regulatory+T+lymphocytes+and+IL2Ra+and+FOXP3+gene+expression+in+peripheral+mononuclear+cells+from+patients+with+amyotrophic+lateral+sclerosis&rft.jtitle=Irish+journal+of+medical+science&rft.au=Rashid+Chehreh+Bargh%2C+Sara&rft.au=Tafakhori%2C+Abbas&rft.au=Masoumi%2C+Farimah&rft.au=Rahmani%2C+Farzaneh&rft.date=2018-11-01&rft.pub=Springer+London&rft.issn=0021-1265&rft.eissn=1863-4362&rft.volume=187&rft.issue=4&rft.spage=1065&rft.epage=1071&rft_id=info:doi/10.1007%2Fs11845-018-1793-2&rft.externalDocID=10_1007_s11845_018_1793_2 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-1265&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-1265&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-1265&client=summon |